David A. Siegel Edgewise Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 96,000 shares of EWTX stock, worth $3.39 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,000
Previous 92,400
3.9%
Holding current value
$3.39 Million
Previous $1.69 Million
2.55%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
147Shares Held
96.8MCall Options Held
45.7KPut Options Held
5.3K-
Orbimed Advisors LLC San Diego, CA15MShares$531 Million6.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$315 Million2.42% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$213 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$206 Million1.4% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$196 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $2.23B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...